Effects of ketoconazole and valproic acid on the pharmacokinetics of the next generation NNRTI, lersivirine (UK‐453,061), in healthy adult subjects

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Lersivirine (UK‐453,061) is predominantly cleared by glucuronidation (UGT2B7) and oxidation via cytochrome P450 (CYP) 3A4. • Lersivirine metabolism, and thus pharmacokinetics, may be affected by concomitant administration of drugs affecting CYP3A4 and UGT2B...

Full description

Saved in:
Bibliographic Details
Published in:British journal of clinical pharmacology Vol. 73; no. 5; pp. 768 - 775
Main Authors: Langdon, Grant, Davis, John, Layton, Gary, Chong, Chew‐Lan, Weissgerber, Georges, Vourvahis, Manoli
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01.05.2012
Blackwell
Blackwell Science Inc
Subjects:
ISSN:0306-5251, 1365-2125, 1365-2125
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first